BROCCO, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 969
NA - Nord America 923
AS - Asia 410
SA - Sud America 62
AF - Africa 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.373
Nazione #
US - Stati Uniti d'America 909
IT - Italia 437
SG - Singapore 267
IE - Irlanda 176
SE - Svezia 104
CN - Cina 63
DE - Germania 62
BR - Brasile 59
FR - Francia 31
NL - Olanda 26
RU - Federazione Russa 21
TR - Turchia 20
FI - Finlandia 19
UA - Ucraina 19
VN - Vietnam 18
GB - Regno Unito 15
AT - Austria 14
CZ - Repubblica Ceca 14
IN - India 12
CA - Canada 11
HK - Hong Kong 11
BE - Belgio 9
LT - Lituania 8
PK - Pakistan 5
IQ - Iraq 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
JP - Giappone 3
ZA - Sudafrica 3
BD - Bangladesh 2
ES - Italia 2
GR - Grecia 2
KR - Corea 2
MX - Messico 2
PT - Portogallo 2
RO - Romania 2
AL - Albania 1
AR - Argentina 1
CO - Colombia 1
EE - Estonia 1
EU - Europa 1
JM - Giamaica 1
MA - Marocco 1
PY - Paraguay 1
SC - Seychelles 1
Totale 2.373
Città #
Singapore 189
Chandler 180
Dublin 171
Pescara 128
Chieti 81
Ashburn 61
The Dalles 58
Jacksonville 49
Princeton 46
Santa Clara 46
Altamura 23
Munich 23
Boardman 21
Los Angeles 20
Ancona 19
Rome 19
Amsterdam 17
Dong Ket 17
Izmir 17
Wilmington 17
Ann Arbor 13
Ascoli Piceno 12
Dearborn 12
New York 12
Nuremberg 12
Brno 11
Beijing 10
Frankfurt am Main 10
Vienna 10
Brussels 9
Hong Kong 9
Milan 9
Houston 8
Lanciano 8
Nanjing 8
Norwalk 8
Pune 8
Helsinki 7
L’Aquila 7
Washington 7
Corridonia 6
Falls Church 6
Lappeenranta 6
Oklahoma City 6
Seattle 6
Islamabad 5
Ottawa 5
Turku 5
Woodbridge 5
Bologna 4
Cambridge 4
Carini 4
Charlotte 4
Düsseldorf 4
Lauterbourg 4
Loma Linda 4
San Benedetto del Tronto 4
Toronto 4
Bari 3
Belo Horizonte 3
Brasília 3
Changsha 3
Curitiba 3
Dubai 3
Guangzhou 3
Jiaxing 3
Johannesburg 3
London 3
Montesilvano Marina 3
Nanchang 3
Olomouc 3
Padova 3
Perego 3
Perth 3
Portsmouth 3
Sulmona 3
Xi'an 3
Ameno 2
Andover 2
Antrodoco 2
Athens 2
Bergamo 2
Camerino 2
Campinas 2
Carugate 2
Chicago 2
Council Bluffs 2
Edinburgh 2
El Segundo 2
Garden City 2
Grevenbroich 2
Hangzhou 2
Livorno 2
Loreto Aprutino 2
Madrid 2
Mascalucia 2
Moscow 2
Najaf 2
Natal 2
Oxford 2
Totale 1.581
Nome #
Breast cancer "tailored follow-up" in Italian oncology units: A web-based survey 126
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 111
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation 106
Exosomes as pleiotropic players in pancreatic cancer 97
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 95
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 90
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 88
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 84
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment 83
Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study 82
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 81
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 80
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 80
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation" 77
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 76
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A “snapshot” from clinical practice 73
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer 72
Drug repurposing, an attractive strategy in pancreatic cancer treatment: Preclinical and clinical updates 69
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 66
Phenotypic and proteomic analysis identifies hallmarks of blood circulating extracellular vesicles in NSCLC responders to immune checkpoint inhibitors 66
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 65
Multi-omics staging of locally advanced rectal cancer predicts treatment response: a pilot study 63
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective 63
Flow Cytometry Detection of Anthracycline-Treated Breast Cancer Cells: An Optimized Protocol 62
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents 62
Screening of Benzimidazole-Based Anthelmintics and Their Enantiomers as Repurposed Drug Candidates in Cancer Therapy 61
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 54
Prognostic value of gender and primary tumor location in metastatic colon cancer 52
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 46
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial 46
Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses 43
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer 38
Deep polychromatic flow cytometry characterization of circulating endothelial cells in metastatic colorectal cancer patients 38
P1.09 Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC 37
Novel strategies exploiting interleukin-12 in cancer immunotherapy 37
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity 32
From cachexia to obesity: the role of host metabolism in cancer immunotherapy 21
null 21
Low Phosphatidylserine+ Cells Within the CD34+/CD45dim/CD117(c-kit)+ Subpopulation Are Associated with Poor Outcomes in Metastatic Colorectal Cancer 16
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy 9
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 7
Totale 2.575
Categoria #
all - tutte 13.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021124 26 0 18 3 5 21 2 4 5 5 3 32
2021/2022179 2 5 8 52 2 25 12 8 11 3 12 39
2022/2023578 38 70 77 52 38 93 29 76 58 5 17 25
2023/2024423 35 5 25 32 10 132 64 16 11 17 7 69
2024/20251.054 39 171 177 53 24 54 151 67 97 80 108 33
Totale 2.575